Hepatitis BE Antibody
Also known as: HBe Antibody, Anti-Hepatitis Be
Use
HBeAb (Hepatitis B e Antibody) appears in the early convalescence phase of hepatitis B virus (HBV) infection. Its presence typically indicates a transition toward recovery or lower infectivity; in chronic hepatitis or carrier states, HBeAb may not develop. Thus, detection of HBeAb can help evaluate the stage of HBV infection and assess infectivity status.
Special Instructions
Not provided.
Limitations
Results from immunosuppressed patients should be interpreted with caution. Patients receiving mouse antibody therapy may produce false-negative results. False-positive results may occur shortly after influenza immunization or in individuals with hypergammaglobulinemia, positive rheumatoid factor, or connective tissue disorders.
Methodology
Immunoassay (Other)
Biomarkers
Hepatitis B e Antibody (HBeAb)
Analyte
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
1 mL
Container
SST tube
Collection Instructions
Draw one SST and send serum at room temperature
Causes for Rejection
Gross hemolysis • Grossly lipemic • Plasma
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant